Pneumocystis jirovecii pneumonia: Difference between revisions
No edit summary |
|||
| Line 43: | Line 43: | ||
==Treatment== | ==Treatment== | ||
[[Pneumocystis jirovecii pneumonia medical therapy|Medical Therapy]] | [[Pneumocystis jirovecii pneumonia | [[Pneumocystis jirovecii pneumonia medical therapy|Medical Therapy]] | [[Pneumocystis jirovecii pneumonia primary prevention|Primary Prevention]] | [[Pneumocystis jirovecii pneumonia secondary prevention|Secondary Prevention]] | Pneumocystis jirovecii pneumonia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Pneumocystis jirovecii pneumonia future or investigational therapies|Future or Investigational Therapies]]] | ||
{{WH}} | {{WH}} | ||
Revision as of 15:38, 27 September 2012
Template:DiseaseDisorder infobox
|
Pneumocystis jirovecii pneumonia Microchapters |
|
Differentiating Pneumocystis jirovecii pneumonia from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pneumocystis jirovecii pneumonia On the Web |
|
American Roentgen Ray Society Images of Pneumocystis jirovecii pneumonia |
|
Risk calculators and risk factors for Pneumocystis jirovecii pneumonia |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Pneumocystis carinii
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Pneumocystis jirovecii pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Pneumocystis jirovecii pneumonia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | Future or Investigational Therapies]